Evaluating the Trump Effect on Global Equities
By Mark Phelps, Dev Chakrabarti
March 02, 2017
US economic policies have always mattered to international investors. While President Trump’s agenda is still taking shape, equity investors can already map out broad guidelines for identifying winners and losers among companies outside the US.
In a recent blog, our colleague Jim Tierney outlined a <html><body><ins>checklist</ins></body></html> for selecting US companies that could do well in an era of unpredictable policymaking. While US companies are on the front lines of changes emanating from Washington, firms around the world will be affected as well. Looking at the issues from a global perspective can help investors frame the criteria that should influence a selective stock-picking process in a changing world (Display).
PERSPECTIVES ON TRADE
Trade and tariffs are a hot topic. But the potential impact of new policies aimed at defending US industry is not so clear-cut.
Some international companies could actually benefit from an increase of US tariffs. That may sound counterintuitive, but non-US multinationals with significant US production for the US market might come out ahead if imports become less competitive.
From a country perspective, China might not be as vulnerable as widely believed. Since the world’s most populous nation buys a lot of US goods, Trump may be deterred from taking a hard line on Beijing, in our view. At the same time, we think Germany might get hit harder than expected by tariffs, given its large trade surplus with the US. While we don’t think that “top-down” perspectives based on country economic outlooks should drive portfolio construction, these dynamics are important to consider in company-specific analyses.
TAX CUTS MATTER FOR MULTINATIONALS
US tax cuts aren’t purely a domestic US issue. Non-US multinational firms that pay a high US tax rate could benefit from a Trump tax cut. Still other multinationals that rely on international treaties to reduce the amount of tax paid in the US could be vulnerable to new efforts to clamp down on tax avoidance.
Fiscal spending priorities are poised to change under Trump. That could spell good news for international suppliers to the US infrastructure and defense industries. Other sectors such as pharmaceuticals, could find themselves at Trump’s mercy; if high drug prices become a policy target to reduce expenditures, international drugmakers with big business interests in the US could take a hit.
Many of Trump’s stated policies could support a sustained strengthening of the US dollar. For non-US companies with significant US sales, this could help boost profits when translated back to home currencies. For others, a strengthening US dollar could push up raw material prices, which threatens to hurt earnings.
INTEREST RATES AND CAPITAL ALLOWANCES
The appreciating dollar reflects expectations that US inflation may rise under Trump’s presidency, which could fuel a sustained increase in interest rates. Here, too, the effects on non-US companies are diverse. Companies with dollar-denominated debt might be vulnerable to higher financing costs, particularly in emerging markets, where dollar-denominated borrowing is commonplace.
Trump has also touted increasing the amount of capital allowance that companies can write off quickly for investment. We believe that a move like this would encourage global companies to boost their investments in the US, particularly in the technology sector. At the same time, interest charges may be disallowed as an expense against taxes, which would suppress the amount of capital available for US companies to launch takeovers and buy back shares. This would level the playing field between US and international companies, which do not always enjoy similar deductible interest benefits, and would make some international companies appear more attractive.
PLOTTING THE IMPACT OF COMPLEX POLICY CHANGES
Taken together, we can begin to plot a roadmap to help investors navigate Trump’s impact on global markets (Display). In a schematic plot of three major variables—tax cuts, tariffs and the US dollar—<html><body><ins>small- and mid-cap US companies</ins></body></html> appear very attractive as their domestic-market focus benefits on all counts.
Multinational companies with US production also stand to do well from tax cuts and higher barriers to imports. Exporters to the US, as well as countries such as Germany and Mexico, could come out on the losing end as the combination of protectionist positions and unfavorable currency dynamics erodes their market positions in the US.
Of course, mapping out the potential effects of a new US policy direction is just one piece of a thorough fundamental analysis of a company’s business environment, earnings drivers and balance sheets. Yet focusing a lens on potential policy outcomes is an increasingly important component for isolating select investment candidates that could deliver solid returns in highly unpredictable times.
The views expressed herein do not constitute research, investment advice or trade recommendations and do not necessarily represent the views of all AB portfolio-management teams. AllianceBernstein Limited is authorised and regulated by the Financial Conduct Authority in the United Kingdom.
Originally Published at: Evaluating the Trump Effect on Global Equities